Navigation Links
NeoStem, Inc. Officially Launches Adult Stem Cell Collection Center and R&D Laboratory in Cambridge, Massachusetts
Date:4/27/2010

NEW YORK, April 27 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced the official launch of the Company's Adult Stem Cell Collection Center and Research & Development ("R&D") laboratory at the Company's 8,000 square foot facility at the Riverside Technology Center in Cambridge, Massachusetts.

The NeoStem Cambridge Center launch will be marked by an on-site ribbon-cutting event, speakers program and facility tour scheduled for Tuesday, April 27th, at 12:00 p.m. at 840 Memorial Drive on the 4th Floor. The launch event will be hosted in association with The Massachusetts Life Sciences Center and the Massachusetts Biotechnology Council (MassBio), of which NeoStem is a member. Featured speakers scheduled to participate in the special event include:

    -- Timothy Murray, Massachusetts Lieutenant Governor
    -- Robin Smith, M.D., Chairman and CEO of NeoStem
    -- Susan Windham-Bannister, President and CEO Massachusetts Life Sciences
       Center
    -- Robert Coughlin, MassBio President and CEO
    -- Wayne Marasco, M.D., Ph.D., Chairman of NeoStem's Scientific Advisory
       Board

The program's distinguished speakers will discuss not only the exciting adult stem cell research they will be conducting for therapeutic development, but also the impact NeoStem will make in the Cambridge community.

"We are excited about the off
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
2. NeoStem, Inc. Names Edward Geehr, M.D. to Board of Directors; Biotechnology Executive Brings Scientific and Business Experience in Global Operations
3. BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University
4. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
5. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
6. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
7. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
8. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
9. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
10. Premier Micronutrient Launches Supplement for Hearing Health
11. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... 2014  Boston Scientific has released the primary ... Heart Failure (NECTAR-HF) clinical trial, the first and ... stimulation (VNS) for the treatment of heart failure ... and Cardiology and Director of the Clinical Investigation ... et de la Recherche Medicale presented the results ...
(Date:8/30/2014)... , Aug. 30, 2014   Royal Philips  (NYSE: ... Affiniti, a new ultrasound system designed to enable ... of increasing patient volumes and cost pressures. Making its ... in Barcelona this week, ... more patients with fewer resources deliver high quality patient ...
(Date:8/29/2014)... -- Market Research Report on Global and Chinese ... and in-depth market survey on Global and ... firstly reviews the basic information of X-Ray Crystallography ... The report then explores global and China,s top ... specification, capacity, Production value, and market share etc. ...
Breaking Medicine Technology:Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 3Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 4Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5
... MINNEAPOLIS, Oct. 4 BridgePoint Medical, Inc., a ... catheter-based systems for chronic total occlusion (CTO) recanalization, ... 16 center, 147 patient U.S. FAST-CTOs (Facilitated Antegrade ... Occlusions) study was designed to assess the safety ...
... a blocked heart artery isn,t the only procedure that ... in a thigh artery and into a heart artery. ... (Logo: http://photos.prnewswire.com/prnh/20100222/AHSALOGO ) ... process of creating a hole in an "access artery" ...
Cached Medicine Technology:BridgePoint Medical®, Inc. Completes and Submits to FDA in the U.S. FAST-CTOs With the CrossBoss® and Stingray® CTO Recanalization System 2BridgePoint Medical®, Inc. Completes and Submits to FDA in the U.S. FAST-CTOs With the CrossBoss® and Stingray® CTO Recanalization System 3Guidelines on Using Artery-Closing Devices: Devices Are OK, But More Research Needed 2
(Date:8/30/2014)... A new method to predict the optimal number ... at ESC Congress today by Dr Benjamin Dahan from ... AEDs located in public places for optimal prevention of ... said: "Out of hospital cardiac arrest is a major ... 50 and 100 per 100 000 in the general ...
(Date:8/30/2014)... Sunday 31 August 2014: Local anaesthetic is as safe ... general anaesthetic, according to results of the FRANCE 2 ... Chopard from France. , Dr Chopard said: "Numerous studies ... for patients with severe symptomatic aortic stenosis who are ... aortic valve replacement. The number of TAVI procedures in ...
(Date:8/30/2014)... A retrievable and repositionable transcatheter aortic valve is ... according to research presented at ESC Congress 2014 ... direct flow medical (DFM) transcatheter aortic valve has ... the potential to improve transcatheter aortic valve implantation ... , Dr Pyxaras said: "TAVI is well established ...
(Date:8/30/2014)... 31 August 2014: A new batteryless cardiac pacemaker ... heart motion was presented at ESC Congress 2014 ... device does not require battery replacement. , Mr ... Group at ARTORG, University of Bern, Switzerland, said: ... implants. Once they reach a critically low energy ...
(Date:8/30/2014)... 31, 2014 Walking-Canes.Net has released ... a mobility device can help in making gait problems easier. ... download from the website that contains all of the news ... site. , The articles deal with diseases that make walking ... walking cane can help in making life easier for the ...
Breaking Medicine News(10 mins):Health News:New method predicts optimal number and location of AEDs 2Health News:Local anesthetic for TAVI as safe and effective as general anesthetic 2Health News:Retrievable transcatheter aortic valve effective and safe in real world setting 2Health News:Batteryless cardiac pacemaker is based on automatic wristwatch 2Health News:Information Articles on Gait Problems from Walking-Canes.Net 2
... earlier use of antibiotics for blood infection , , TUESDAY, ... in Spain to promote appropriate care for severe sepsis ... adherence and a lower rate of sepsis deaths in ... accounts for one in five admissions to intensive care ...
... giving again, experts warn , , TUESDAY, May 20 (HealthDay News) ... time of decreasing blood donations, a new study shows that ... 17-year-olds, are more likely to bruise, faint or experience other ... of young donors may be less likely to give in ...
... A new 12-week study2examined safety and efficacy ... (budesonide/formoterol fumarate dehydrate) Inhalation Aerosol,2 in treating mild ... to 15 years old2 who were previously treated ... study included efficacy assessments of nighttime symptoms, nighttime ...
... Vista Partners announced today that,it has initiated ... ).,Ross Silver, Director of Research of Vista Partners ... encouraging,clinical and preclinical data to date. Cethrin would ... to Cethrin, Alseres has a molecular,imaging program in ...
... May 20 Ambulatory Services of,America, Inc. announced ... fourth,joint venture to provide outpatient radiation oncology services. ... Cancer Center, LP and ASA,s,subsidiary, Radiation Oncology Services ... operate a radiation therapy facility in Denton, Texas ...
... the thought of baring your,pasty, dry, winter skin makes ... from the International SPA Association have you,covered with some ... in,time for summer! There,s no doubt you,ll be turning ... ISPA member spa prepping for the hot months,ahead., ...
Cached Medicine News:Health News:Educational Drive Cut Death Rate From Sepsis 2Health News:Teen Blood Donors More Prone to Complications 2Health News:Teen Blood Donors More Prone to Complications 3Health News:Study analyzed SYMBICORT in children with persistent asthma 2Health News:Study analyzed SYMBICORT in children with persistent asthma 3Health News:Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) 2Health News:Ambulatory Services of America, Inc. Announces Joint Venture With Denton Cancer Center, LP 2Health News:10 Ways to Stay Cool This Summer With Hot Spa Products and Treatments 2Health News:10 Ways to Stay Cool This Summer With Hot Spa Products and Treatments 3
... is based on SIREMOBIL Iso-C, the first ... the intra-operative 3D-Mode, the 3D-dataset is immediately ... orbital movement. This allows the surgeon to ... during the procedure. This 3D capability is ...
... Humphrey Field Analyzer II-i series is a ... the patient's visual field. ,By using SITA, ... is reduced by up to 70%. ,A ... ergonomic design to increase patient comfort while ...
... an innovative device designed to be a ... abdominal aortic aneurysms (AAA). It is constructed ... an outer self-expanding Nitinol support structure to ... The function of the endoprosthesis is to ...
... a cast from an arm or leg can ... cut or burned by the cast saw blade. ... remove any cast with confidence. This innovative, cut-resistant ... burns from the cast saw and can be ...
Medicine Products: